Dysfunctional T regulatory cells in multiple myeloma.

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Multiple myeloma (MM) is marked by abnormal immunoglobulin production and impaired T-cell immunity.
• The underlying mechanisms of T-cell dysfunction in MM are not fully understood.
• T regulatory (Treg) cells are crucial for maintaining immune homeostasis.

Purpose of the Study:

• To investigate the role of T regulatory (Treg) cells in immune dysfunction associated with MM.
• To compare Treg cell numbers and function in patients with MM and monoclonal gammopathy of undetermined significance (MGUS) versus healthy individuals.

Main Methods:

• Flow cytometry was used to quantify CD4+ CD25+ T cells and T regulatory (Treg) cells (via FOXP3 expression).
• In vitro assays assessed the suppressive capacity of Treg cells on T-cell proliferation.
• Patients with MM, MGUS, and healthy donors were included in the comparative analysis.

Main Results:

• Patients with MGUS and MM exhibited a significant increase in CD4+ CD25+ T cells compared to healthy donors.
• However, FOXP3+ Treg cell numbers were significantly decreased in both MGUS and MM patient groups.
• Treg cells from MM and MGUS patients demonstrated impaired ability to suppress T-cell proliferation.

Conclusions:

• A reduced number and compromised function of T regulatory (Treg) cells contribute to immune dysfunction in monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).
• This Treg cell deficit may explain the observed increase in CD4+ CD25+ T cells and overall T-cell dysfunction in these conditions.